What aidhere does

aidhere, operating in Germany through its subsidiary Sidekick Health Germany GmbH (Hamburg), develops prescription-based digital health applications targeting chronic disease treatment, with a primary focus on the holistic, data-driven management of obesity. Its flagship product, zanadio, became the first digital obesity therapy approved for prescription reimbursement in Germany when it received clearance from the Federal Institute for Drugs and Medical Devices (BfArM) in October 2020 as the third application admitted under the DiGA (Digitale Gesundheitsanwendungen) framework. The therapeutic methodology is grounded in behavioral psychology, neuroscientific knowledge, and AI-augmented personalization, positioning zanadio as a clinically validated 90-day behavioral intervention.

The business model is anchored in the German statutory health insurance reimbursement pathway: physicians prescribe approved DiGAs to eligible patients, and reimbursement flows from statutory payers to the provider. This produces a prescription-channel GTM with marketing concentrated on healthcare professionals and patient-facing awareness via social media (LinkedIn, Twitter/X, Facebook). aidhere markets itself as an enterprise-grade provider, supported by ISO 27001 information security certification and product traceability through the official DiGA.info platform. The company reports 15,000+ treated patients as a scale credential.

aidhere has stated intent to broaden zanadio's indication coverage and develop additional digital therapies beyond obesity, signaling a multi-product DiGA portfolio strategy. The company is privately held, has secured early-stage capital from SpinLab (HHL Accelerator), Hevella Capital, and Peak Pride, and maintains a 101-250 employee operating base. Today its commercial footprint is single-country (Germany), with deep embedding in national digital health industry associations (Spitzenverband Digitale Gesundheitsversorgung, Bitkom, Bundesverband Deutsche Startups) and Hamburg's regional innovation cluster as a distribution and policy-influence strategy.

Name

aidhere

Legal name

Sidekick Health Germany GmbH

Website

https://aidhere.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

101–250 employees

Short description

aidhere (operating as Sidekick Health Germany GmbH) develops prescription-based digital health applications for chronic disease treatment in Germany, with zanadio being its BfArM-approved digital obesity therapy reimbursed through German statutory health insurance.

Ownership category

akta.pro rank

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Digital Health Application (DiGA) Sales: As an approved DiGA (Digitale Gesundheitsanwendungen) provider in Germany, the company generates revenue through the German healthcare system by providing prescription-based digital therapies that are reimbursed through statutory health insurance.

Distribution channels1 record

Marketing channels3 records

Core offering

aidhere develops prescription digital health applications (DiGA) for the holistic treatment of chronic diseases, with its flagship product zanadio providing BfArM-approved, app-based obesity therapy delivered to patients in the German healthcare system. The applications deliver data-driven, personalized interventions based on behavioral psychology, neuroscientific knowledge, and AI research to drive long-term patient behavioral change.

Product overview

aidhere develops digital health applications for the holistic treatment of diseases, operating as a unified product portfolio centered on its approved digital therapeutics. The primary product is zanadio, a prescription-based digital obesity therapy and the first of its kind approved in Germany. The company is currently expanding zanadio and developing therapies for other indications, all built on behavioral psychology, neuroscientific knowledge, and AI research approaches.

Differentiator

Problem solved

Functional benefit

Brands

• zanadio: Digital obesity therapy on prescription - the first digital health application approved by BfArM for treating obesity.

Products and services

• zanadio zanadio is a prescription-based digital health application (DiGA) for the treatment of obesity, approved by the Federal Institute for Drugs and Medical Devices (BfArM). It delivers data-driven, app-based therapy grounded in behavioral psychology, neuroscientific knowledge, and AI research to support long-term weight management and behavioral change in patients.

Quantifiable outcome

• 15,000+ patients treated

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature1 record

Partnerships

Ten partnerships are on record, tiered minor and core.

• BitkomminorOthersTechnology association membership for digital health industry networking and advocacy in Germany.
• Spitzenverband Digitale GesundheitsversorgungcoreOthersLeading association for digital healthcare in Germany, representing interests in digital health policy and implementation.
• Bundesverband Deutsche StartupsminorOthersGerman startup association membership providing access to startup ecosystem and networking opportunities.
• Life Science NordminorOthersRegional life sciences cluster in Hamburg, providing networking and support for healthcare companies.
• DiGA infocoreOthersOfficial information platform for Digital Health Applications (DiGA) in Germany, supporting visibility and patient access.
• Health Innovation PortminorOthersHamburg-based healthcare innovation hub providing incubation and acceleration support.
• IFB InnovationsstarterminorOthersInnovation starter program in Hamburg supporting new company development and growth.
• Digital Health Hub HamburgminorOthersHamburg-based digital health ecosystem hub connecting startups and healthcare stakeholders.
• SpinLab – The HHL AcceleratorminorOthersLeipzig-based accelerator affiliated with HHL Leipzig Graduate School of Management, providing startup acceleration services.
• CMSminorOthersLegal partnership for corporate and regulatory legal counsel.

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• WW International (Weight Watchers): Global incumbent in weight management and behavior-change programs. Comparable as a large established player in the same disease area and behavior-change category, addressing the same patient population through a different delivery model.
• Noom: Large-scale, global consumer digital weight management platform using behavioral coaching and psychology. Comparable as a broad incumbent in digital obesity management targeting an overlapping patient segment, though operating via consumer/employer rather than reimbursement.

Others

• Sidekick Health: Icelandic digital therapeutics company that is the operating parent of Sidekick Health Germany GmbH (aidhere). Relevant as the parent platform exposing zanadio to broader chronic care partnerships, though it is an affiliated entity rather than an independent competitor.

Direct peers

• Oviva: Europe-leading digital nutritional counseling and weight management provider operating in Germany, Switzerland, the UK, and France. Comparable as a scaled digital obesity/weight management competitor with overlapping patient populations and disease-management payer relationships.
• HelloBetter: One of Germany's largest DiGA providers with multiple approved digital therapeutics for mental health. Comparable as a scaled, well-funded German prescription digital therapeutic operator sharing the BfArM-approved, payer-reimbursed GTM motion.
• Selfapy: Berlin-based DiGA provider offering prescription digital therapeutics for mental health conditions. Directly comparable business model (BfArM-approved DiGA, reimbursed by German statutory health insurance) competing in the same regulatory and reimbursement framework as zanadio.
• Virta Health: US-based digital therapeutics company reversing type 2 diabetes and obesity via medically-supervised, behaviorally-driven remote care. Comparable as a prescription-grade digital therapeutic in chronic metabolic disease with a similar clinical-and-AI thesis to zanadio.
• Vivira: Berlin-based DiGA provider offering a prescription digital therapeutic for musculoskeletal back pain. Comparable as a German DiGA competing in the same BfArM-approved, physician-prescribed, statutory-insurer-reimbursed model.
• Mindable Health: DiGA provider offering a prescription digital therapeutic for panic disorder and anxiety. Directly comparable as a German DiGA operator selling reimbursed behavioral digital therapies into the same statutory health insurance system.
• Sympatient: Hamburg-based DiGA provider of a prescription digital therapeutic for agoraphobia and anxiety disorders. Comparable as a German DiGA in the same reimbursement pathway, with overlapping regional ecosystem ties (Hamburg health innovation scene).

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/aidhere_DE
• Facebookfacebook.com/aidhereDE
• LinkedInlinkedin.com/company/14794486

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about aidhere